Explore drug information in your own words.
Type a question in the search bar above to get started. Each question is answered independently.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| antibiotics, 6-aminopenicillanic acid derivatives | 1025 | 26774-90-3 |
| Dose | Unit | Route |
|---|---|---|
| 2 | g | O |
| 2 | g | P |
None
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| azlogd74 | LogD at pH 7.4 | -1.524 | Moderate | 0.65 | |
| caco2-efflux | Caco-2 efflux ratio (BA/AB) | 0.637 | Moderate | 0.65 | |
| caco2-intrinsic-papp | Caco-2 intrinsic apparent permeability | 0.333 | 10^-6 cm/s | Moderate | 0.65 |
| dh-clint | Dog hepatocyte intrinsic clearance | 2.075 | uL/min/10^6 cells | Moderate | 0.65 |
| dppb | Dog plasma protein binding (% unbound) | 88.610 | % | Moderate | 0.65 |
| fcs-ppb | Fetal calf serum protein binding (% unbound) | 75.590 | % | Moderate | 0.65 |
| herg | hERG pIC50 | 4.312 | pIC50 | Moderate | 0.65 |
| hh-clint | Human hepatocyte intrinsic clearance | 1.422 | uL/min/10^6 cells | Moderate | 0.65 |
| hlm-clint | Human liver microsomal intrinsic clearance | 3.105 | uL/min/mg protein | Moderate | 0.65 |
| hppb | Human plasma protein binding (% unbound) | 89.660 | % | Moderate | 0.65 |
| kinase-safety-class | ACVR2A,ACVR2B,AURKA,AXL,BRAF,BTK,CAMK2D,CDK4,CDK5,CDK9,DDR1,DYRK1B,EGFR,EIF2AK3,ERBB2,GRK2,GSK3B,ITK,JAK2,JAK3,KDR,MAP2K6,MAP3K14,MAP3K21,MAP3K7,MAPK10,MAPK7,MAPKAPK2,NTRK2,PDK1,PDK2,PIK3CB,PIM2,PRKDC,SIK2,STK33,SYK,TEK,TGFBR1,ZAP70 | 40 | |||
| kinase-selectivity-class | AXL,GRK2,MAP2K6,TGFBR1 | 4 | |||
| mdck-mdr1-bcrp-efflux | MDCK-MDR1-BCRP efflux ratio | 0.431 | Moderate | 0.65 | |
| mdck-mdr1-efflux | MDCK-MDR1 efflux ratio | 0.791 | Moderate | 0.65 | |
| mh-clint | Mouse hepatocyte intrinsic clearance | 1.816 | Moderate | 0.65 | |
| mppb | Mouse plasma protein binding (% unbound) | 88.590 | Moderate | 0.65 | |
| nih-mdck-mdr1-efflux | NIH MDCK-MDR1 efflux ratio | 1.514 | Moderate | 0.65 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| pppb | Pig plasma protein binding (% unbound) | 80.940 | % | Moderate | 0.65 |
| rat-kpuu-brain | Rat brain Kpuu | 0.007 | % | Moderate | 0.65 |
| rh-clint | Rat hepatocyte intrinsic clearance | 1.119 | uL/min/10^6 cells | Moderate | 0.65 |
| rh-fuinc | Rat hepatocyte fraction unbound in incubation | 91.120 | % | Moderate | 0.65 |
| rppb | Rat plasma protein binding (% unbound) | 86.290 | % | Moderate | 0.65 |
| solubility-dd | Solubility at pH 7.4 in DMSO | 937.562 | uM | Moderate | 0.65 |
None
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | J01CA07 | ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE BETA-LACTAM ANTIBACTERIALS, PENICILLINS Penicillins with extended spectrum |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000900 | Anti-Bacterial Agents |
| CHEBI has role | CHEBI:33282 | antibacterial agent |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 2.79 | acidic |
| pKa2 | 7.56 | Basic |
None
None
None
| ID | Source |
|---|---|
| D04020 | KEGG_DRUG |
| C0059424 | UMLSCUI |
| CHEBI:58974 | CHEBI |
| CHEMBL2104266 | ChEMBL_ID |
| DB13300 | DRUGBANK_ID |
| C100212 | MESH_SUPPLEMENTAL_RECORD_UI |
| 71392 | PUBCHEM_CID |
| 10804 | IUPHAR_LIGAND_ID |
| 2996 | INN_ID |
| 3LU1L73C8Y | UNII |
| 34983009 | SNOMEDCT_US |
None